» Articles » PMID: 31372045

Stanniocalcin 2 (STC2) Expression Promotes Post-radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2019 Aug 3
PMID 31372045
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Stanniocalcin 2 (STC2) expression is upregulated under multiple stress conditions including hypoxia, nutrient starvation and radiation. Overexpression of STC2 correlates with tumor progression and poor prognosis. We previously demonstrated that overexpression of STC2 in nasopharyngeal carcinomas (NPC) positively correlates with radiation resistance and tumor metastasis, two major clinical obstacles to the improvement of NPC management. However, it remains elusive whether STC2 expression is a critical contributing factor for post-radiation survival and metastasis of NPC cells. Using the radiation resistant CNE2 cell line as a model, we examined the importance of STC2 expression for post-radiation survival, migration and invasion. Here, we report the establishment of STC2 knockout lines (CNE2-STC2-KO) using the CRISPR/Cas9-based genome editing technique. Compared with the parental line, STC2-KO cells showed similar proliferation and morphology in normal culture conditions, and loss of STC2 did not compromise the cell tumorigenicity in nude mice model. However, STC2-KO lines demonstrated increased sensitivity to X-radiation under either normoxic or hypoxic conditions. Particularly, upon X-radiation, parental CNE2 cells only slightly whereas STC2-KO cells remarkably decreased the migration and invasion ability. Cell cycle analysis revealed that loss of STC2 accumulated cells in G and G/M phases but decreased S-population. These data indicate that the expression of STC2, which can be stimulated by metabolic or therapeutic stresses, is one important factor to promote survival and metastasis of post-radiation NPC cells. Therefore, targeting STC2 or relative downstream pathways may provide novel strategies to overcome radiation resistance and metastasis of NPC.

Citing Articles

Predictive Value of Gene Expression in Chemotherapy Response in Breast Cancer.

Munoz J, Lampe-Huenul N Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006048 PMC: 11859796. DOI: 10.3390/ph18020235.


Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma.

Wu H, Cao S, Xu Z, Wang T, Ji G, Wang K BMC Cancer. 2025; 25(1):131.

PMID: 39849389 PMC: 11756198. DOI: 10.1186/s12885-025-13433-4.


Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress.

Qie S, Xiong H, Liu Y, Yan C, Wang Y, Tian L Cell Death Dis. 2024; 15(8):567.

PMID: 39107307 PMC: 11303387. DOI: 10.1038/s41419-024-06961-7.


Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress.

Qie S, Xiong H, Liu Y, Yan C, Wang Y, Tian L Res Sq. 2024; .

PMID: 38464261 PMC: 10925426. DOI: 10.21203/rs.3.rs-3904465/v1.


STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma.

Jiang K, Yin X, Zhang Q, Yin J, Tang Q, Xu M Redox Biol. 2023; 60:102626.

PMID: 36764215 PMC: 9929488. DOI: 10.1016/j.redox.2023.102626.


References
1.
Bouras T, Southey M, Chang A, Reddel R, Willhite D, Glynne R . Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res. 2002; 62(5):1289-95. View

2.
Bakkenist C, Kastan M . DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003; 421(6922):499-506. DOI: 10.1038/nature01368. View

3.
Ito D, Walker J, Thompson C, Moroz I, Lin W, Veselits M . Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol. 2004; 24(21):9456-69. PMC: 522226. DOI: 10.1128/MCB.24.21.9456-9469.2004. View

4.
Garnett C, Palena C, Chakraborty M, Chakarborty M, Tsang K, Schlom J . Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res. 2004; 64(21):7985-94. DOI: 10.1158/0008-5472.CAN-04-1525. View

5.
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K . DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005; 434(7035):864-70. DOI: 10.1038/nature03482. View